Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pComb3XSS Citations (5)

Originally described in: Methods for the generation of chicken monoclonal antibody fragments by phage display.
Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas CF 3rd J Immunol Methods. 2000 Aug 28;242(1-2):159-81.
PubMed Journal

Articles Citing pComb3XSS

Articles
Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety. Tang F, LeBlanc ME, Wang W, Liang D, Chen P, Chou TH, Tian H, Li W. Angiogenesis. 2019 Aug;22(3):369-382. doi: 10.1007/s10456-019-09662-4. Epub 2019 Jan 14. PubMed
A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary CaVbeta subunits. Morgenstern TJ, Park J, Fan QR, Colecraft HM. Elife. 2019 Aug 12;8. pii: 49253. doi: 10.7554/eLife.49253. PubMed
A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in brain neurons. Dong JX, Lee Y, Kirmiz M, Palacio S, Dumitras C, Moreno CM, Sando R, Santana LF, Sudhof TC, Gong B, Murray KD, Trimmer JS. Elife. 2019 Sep 30;8. pii: 48750. doi: 10.7554/eLife.48750. PubMed

Associated Plasmids

Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Feng Z, He X, Zhang X, Wu Y, Xing B, Knowles A, Shan Q, Miller S, Hojnacki T, Ma J, Katona BW, Gade TPF, Schrader J, Metz DC, June CH, Hua X. Nat Cancer. 2022 May;3(5):581-594. doi: 10.1038/s43018-022-00344-7. Epub 2022 Mar 21. PubMed
Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins. Yu C, Ding W, Zhu L, Zhou Y, Dong Y, Li L, Liu J, Wang Y, Li Z, Zhu L, Chen F, Ruan M, Qian D, Wang Y, Wu B, Xu H, Li M, Bi Y, Wang H, Wang W, Chao P, Xing L, Shen B, Dai H, Zha L, Zhao H, Wang J. iScience. 2022 Dec 5;26(1):105736. doi: 10.1016/j.isci.2022.105736. eCollection 2023 Jan 20. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.